ABIVAX Société Anonyme
AAVXF
$6.91
$1.0217.32%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 198.49% | 205.57% | 5.22% | 7.88% | 3.12% |
| Total Revenue | 198.49% | 205.57% | 5.22% | 7.88% | 3.12% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 198.49% | 205.57% | 5.22% | 7.88% | 3.12% |
| SG&A Expenses | 216.99% | 224.51% | 338.10% | 349.13% | 217.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -310.53% | -313.16% | -91.96% | -96.40% | 87.25% |
| Total Operating Expenses | 117.09% | 122.24% | 153.37% | 159.75% | 133.86% |
| Operating Income | -112.18% | -117.22% | -162.57% | -169.18% | -153.22% |
| Income Before Tax | -55.38% | -59.07% | -155.14% | -161.57% | -150.65% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -55.38% | -59.07% | -155.14% | -161.57% | -150.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -55.38% | -59.07% | -155.14% | -161.57% | -150.65% |
| EBIT | -112.18% | -117.22% | -162.57% | -169.18% | -153.22% |
| EBITDA | -112.16% | -117.20% | -162.49% | -169.10% | -153.14% |
| EPS Basic | 11.33% | 9.23% | -8.83% | -11.57% | -17.00% |
| Normalized Basic EPS | 11.34% | 9.22% | -19.94% | -22.97% | -116.16% |
| EPS Diluted | 11.33% | 9.23% | -8.83% | -11.57% | -17.00% |
| Normalized Diluted EPS | 11.34% | 9.22% | -19.94% | -22.97% | -116.16% |
| Average Basic Shares Outstanding | 75.24% | 75.24% | 134.43% | 134.43% | 114.23% |
| Average Diluted Shares Outstanding | 75.24% | 75.24% | 134.43% | 134.43% | 114.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
